{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T18:17:54Z","timestamp":1773944274491,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jacep.2023.04.005","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T14:04:17Z","timestamp":1687356257000},"page":"1649-1651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P3","title":["Anti-Ro\/SSA Antibodies in\u00a0Atrioventricular Block"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6209-6488","authenticated-orcid":false,"given":"Joshua A.","family":"Keefe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xander H.T.","family":"Wehrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2023.04.005_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0049-0172(95)80004-2","article-title":"Autoantibodies in the diagnosis of systemic rheumatic diseases","volume":"24","author":"von Muhlen","year":"1995","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jacep.2023.04.005_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-2133.2001.04577.x","article-title":"Antibodies targeting extractable nuclear antigens: historical development and current knowledge","volume":"145","author":"Wenzel","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacep.2023.04.005_bib3","article-title":"Risk of QTc interval prolongation associated with circulating anti-Ro\/SSA antibodies among US veterans: an observational cohort study","volume":"10","author":"Lazzerini","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacep.2023.04.005_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.hrthm.2014.10.031","article-title":"Isolated atrioventricular block of unknown origin in adults and anti-Ro\/SSA antibodies: clinical evidence, putative mechanisms, and therapeutic implications","volume":"12","author":"Lazzerini","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2023.04.005_bib5","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/01.CIR.103.11.1599","article-title":"Direct inhibition of expressed cardiac L- and T-type calcium channels by IgG from mothers whose children have congenital heart block","volume":"103","author":"Xiao","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2023.04.005_bib6","first-page":"1500","article-title":"Anti-Ro52 antibody acts on the S5-pore linker of hERG to chronically reduce channel expression","volume":"115","author":"Szendrey","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2023.04.005_bib7","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/01.cir.0000437597.44550.5d","volume":"129","author":"Donofrio","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2023.04.005_bib8","first-page":"1631","article-title":"Anti-Ro\/SSA antibodies blocking calcium channels as a potentially reversible cause of atrioventricular block in adults","volume":"9","author":"Lazzerini","year":"2023","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacep.2023.04.005_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003432","article-title":"Atrioventricular node dysfunction and ion channel transcriptome in pulmonary hypertension","volume":"9","author":"Temple","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2023.04.005_bib10","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","article-title":"The importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants","volume":"55","author":"Jaeggi","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X23002530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X23002530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:32:37Z","timestamp":1762500757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X23002530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2405500X23002530"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2023.04.005","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Ro\/SSA Antibodies in\u00a0Atrioventricular Block","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2023.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2023.03.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}